COVID-19, new variant of Corona Virus, is an enveloped virus with helical nucleo-capsid that contains single stranded RNA and have distinctive club-shaped surface projections that give appearance of a solar corona to the virion named for Crown like spikes proteins around the lipid envelope.9 Though, exact genetic composition and its variation has not be decrypted. Multiple of published studies show that Novel corona Virus(COVID-19) is sufficiently different from SARS corona virus and is hence a new variant of beta-coronavirus. This novel corona virus might be linked to a zoonotic pathogen. It has been said that this virus might have originated from a zoonotic pathogen as the virus isolated from the affected patient showed the similar corona virus sequence EPI_ISL_402131which is also found in Rhinolophus affinis, an Asian bat predominantly found in China. At least 96% similarity was found between corona virus genome and that of bat relative, however, similarity with the human strain of SARS is much lower of around 80%. Although zoonotic origin of virus is seen, animals sold at the sea food market in Wuhan might represent an intermediate host facilitating the emergence of virus in humans.10,11,12,13,34,36,37,38
In this study, it has been found that fever and cough( both dry and productive), fatigue, shortness of breath and muscle aches were found to be the major symptoms in patients who were diagnosed to be suffering from COVID-19. One of the published retrospective study by Yang et al14, showed that fever, cough and shortness of breath were major symptoms in patients of COVID-19 pneumonia. Centre for disease control(CDC) also listed these symptoms to be the major symptoms.15 Another studies showed that fever, cough and vomiting were among the most common symptoms.16 Similar findings were shown in multiple of other studies.17,18,19,20,21,28,29,30,31,32,33,35,
Similarly, this study shows that the extent of disease severity is largely dependent in patient comorbid conditions. This study shows that Hypertension(HTN), other cardiovascular and cerebrovascular diseases, diabetes mellitus(DM), respiratory disorders like Chronic Obstructive Pulmonary Disease(COPD), other concurrent infections and immunodeficiency states are among major co-morbidities present in individuals suffering fromCOVID-19. In a systematic review by Yang J et al22, HTN,DM, cardiovascular and cerebrovascular conditions, COPD, malignancy and immunosuppressed states were shown among others as the important risk factors. Angiotensin Converting Enzyme inhibitors which is generally used in HTN has warranted a specific concern 42, however, substantial findings are yet to be found. Angiotensin converting enzyme 2 (ACE2) receptors have been shown to be the entry point into human cells for SARS-CoV-2, the virus that causes COVID-19. In a few experimental studies with animal models, both angiotensin converting enzyme (ACE) inhibitors and angiotensin receptor blockers (ARBs) have been shown to upregulate ACE2 expression in the heart. Though these have not been shown in human studies, or in the setting of COVID-19.23 Multiple of published reports show that Diabetes39,40,41, Hypertension43,44,45,46,47and Cardiovascularconditions45,46,47 , Immunosuppressed states48,49,50,51, gastric conditions are among the most common co-morbidities that leads to increased infection, virulence and fatality when an individual is affected by Novel Corona Virus.22,24,